End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,800 KRW | +0.39% |
|
-1.93% | -31.80% |
Jun. 19 | Hyundai Bioscience Co., Ltd. announced that it has received KRW 3 billion in funding | CI |
Jun. 17 | Hyundai Bioscience Co., Ltd. announced that it expects to receive KRW 3 billion in funding | CI |
Business Summary
Number of employees: 63
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bio
100.0
%
| 8,054 | 102.6 % | 9,481 | 100.0 % | +17.73% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Overseas
97.0
%
| 3,887 | 49.5 % | 9,197 | 97.0 % | +136.59% |
South Korea
3.0
%
| 3,964 | 50.5 % | 284 | 3.0 % | -92.82% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sang-Gi Oh
CEO | Chief Executive Officer | 64 | 13-03-28 |
Kwang-Hee Kim
PRN | Corporate Officer/Principal | 58 | - |
Yeong-Kwon Jeong
PRN | Corporate Officer/Principal | 57 | - |
Yong-Ho Cho
AUD | Comptroller/Controller/Auditor | 56 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sang-Gi Oh
CEO | Chief Executive Officer | 64 | 13-03-28 |
Yeong-Kwon Jeong
PRN | Corporate Officer/Principal | 57 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 39,821,608 | 34,678,484 ( 87.08 %) | 2,256 ( 0.005665 %) | 87.08 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ADM KOREA INC. 30.33% | 6,623,641 | 30.33% | 14,435,828 $ |
2,256 | 0.01% | 30,107 $ |
Company contact information
HYUNDAI BIOSCIENCE Co., Ltd.
106 Apogongdan-gil Apo-eup
39670, Gimcheon-si
+
http://www.hyundaibioscience.com![address Hyundai Bioscience Co., Ltd.(A048410)](https://cdn.zonebourse.com/static/address/120962149.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-31.80% | 516M | |
+13.70% | 393B | |
+16.68% | 144B | |
+23.03% | 80.46B | |
-1.54% | 73.78B | |
-29.33% | 37.06B | |
-14.82% | 35.12B | |
+1.95% | 33.77B | |
+12.64% | 18.76B | |
+27.64% | 17.68B |
- Stock Market
- Equities
- A048410 Stock
- Company Hyundai Bioscience Co., Ltd.